BENJAMIN SHIVAR: Open Payments
NPI 1992195184 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,167 in 130 payments from 24 companies in 2025. Trend: 2023 $2,204 · 2024 $2,570 · 2025 $3,167
Food & beverage: $3,167
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $401 |
| Viatris Specialty LLC | 10 | $273 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 15 | $257 |
| Insmed, Inc. | 12 | $217 |
| GENZYME CORPORATION | 8 | $203 |
| GlaxoSmithKline, LLC. | 14 | $201 |
| Verona Pharma, Inc. | 8 | $182 |
| Actelion Pharmaceuticals US, Inc. | 6 | $171 |
| Regeneron Healthcare Solutions, Inc. | 10 | $162 |
| JAZZ PHARMACEUTICALS INC. | 5 | $142 |
Products named: DUPIXENT, YUPELRI, FASENRA, Ohtuvayre, Arikayce, XYWAV, BREZTRI, CHARTIS CATHETER.
Industry payments across FL — which companies pay providers there.
